
View larger version (54K):
[in this window]
[in a new window]
|
Fig. 4. Co-aggregation of keratin and periplakin in Okadaic acid-treated MCF-7 cells. (A) Periplakin (Ppl) domain constructs used in transfection experiments. HA, haemagglutinin tag; Linker; the C-terminal tail of periplakin comprising the IF-binding domain (Ruhrberg et al., 1997 ; DiColandrea et al., 2000 ); Green oval, Enhanced Green Fluorescence Protein. (B) EGFP-Ppl C construct (green) and Keratin 8 (red) in MCF-7 cells. Monolayer panel: left side; EGFP fluorescence, right side; merged image. Wound edge panel: merged image of EGFP-PplC and K8 (red), note the aggregated keratin cytoskeleton in the wound edge cell. (C) Okadaic acid-treated wound edge stained for endogenous periplakin (red) and keratin 8 (green) expression. Periplakin expression is retained at cell borders, whereas the cytoplasmic pool is concentrated in small aggregates (arrowhead) or larger inclusions (arrow). (D) Subcellular fractionation of Okadaic acid and vehicle (DMSO) treated MCF-7 monolayers. S1, Saponin soluble fraction; S2, Triton X-100 soluble fraction; P, Triton insoluble pellet. (E) Transient transfection of EGFP-PplC treated with Okadaic acid. Merged image of EGFP (green) and Keratin immunofluorescence (red). Note similar aggregates (arrowhead) and large inclusion (arrow) to those seen in panel C. (F) Transient transfection of pP-C treated with Okadaic acid. Merged image of HA-tagged Ppl linker domain (green) and Keratin immunofluorescence (red). (G) Transient transfection of pP-NR treated with Okadaic acid. Merged image of HA-tagged Periplakin without linker domain (green) and Keratin immunofluorescence (red). (H) Transient transfection of pP-C treated with SB. Merged image of HA-tagged periplakin linker domain (green) and Keratin immunofluorescence (red). (I) Still images taken at indicated time points from live cell imaging of pEGFP-PplC transfection treated with Okadaic acid.
|